Company
Accuray
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
13
510(k), De Novo and PMA
Device trials
0
As lead sponsor, any status
Adverse event reports
6
Received Nov 1, 2025 to Nov 20, 2026
Recall records
41
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
ARAY
Nasdaq · ACCURAY INC
Public float
$86.9M
Value of shares held by non-insiders on Dec 31, 2025
Revenue
$402M
Fiscal year ending Jun 30, 2026
Net income
-$49.2M
Fiscal year ending Jun 30, 2026
R&D spending
$37.8M
Fiscal year ending Jun 30, 2026
Cash
$42.3M
As of Sep 30, 2026
Long-term debt
$95.0M
As of Sep 30, 2026
Shares outstanding
120.2M
As of Oct 31, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2026 | – | $665K | – | – |
| 2025 | – | $1.6M | – | – |
| 2024 | – | $2.2M | – | – |
| 2023 | – | $2.2M | – | – |
| 2022 | – | $3.9M | – | – |
| 2021 | – | $3.0M | – | – |
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
The 8 newest of 13 since 2015.
K223159 · Decided Jun 23, 2023 · 259 days after receipt
Device type: Accelerator, Linear, Medical (IYE) · Radiology & Imaging
K212794 · Decided Sep 30, 2021 · 28 days after receipt
Device type: Accelerator, Linear, Medical (IYE) · Radiology & Imaging
K202412 · Decided Dec 18, 2020 · 116 days after receipt
Device type: Accelerator, Linear, Medical (IYE) · Radiology & Imaging
10 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
No device trials list this company as lead sponsor.
Reports received
6
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
4
67% of reports
Injury reports
1
17% of reports
Death reports
1
17% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 2 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 | 0 |
| Feb 24 | 0 | 1 | 0 | 0 |
| Mar 24 | 0 | 1 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 | 0 |
| Jul 24 | 1 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 2 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 1 | 0 | 0 |
| Aug 25 | 1 | 1 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 2 | 0 | 0 | 0 |
| Dec 25 | 1 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 1 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 1 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
1 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Cyberknife Treatment Deliver System equipped with the Xchange Robotic Collimator Changer; Linear AcceleratorOpen, Classified
Z-2640-2026 · Started Jun 16, 2026 · Posted by FDA Jul 1, 2026
Reason given: In certain cases, a collimator may not fully dock, which triggers a system interlock and prevents motion from the operator console. If personnel then enter the treatment room and initiate motion using the in-room control pendant, the collimator may release and fall from the housing.
Cause as FDA categorized it: Software design · Device type: Accelerator, Linear, Medical (IYE)
- Cyberknife Treatment Deliver System equipped with the Xchange Robotic Collimator Changer; Linear AcceleratorOpen, Classified
Z-2644-2026 · Started Jun 16, 2026 · Posted by FDA Jul 1, 2026
Reason given: In certain cases, a collimator may not fully dock, which triggers a system interlock and prevents motion from the operator console. If personnel then enter the treatment room and initiate motion using the in-room control pendant, the collimator may release and fall from the housing.
Cause as FDA categorized it: Software design · Device type: Accelerator, Linear, Medical (IYE)
Z-1023-2025 · Started Dec 23, 2024 · Posted by FDA Jan 27, 2025
Reason given: Snap rings may become partially or completed detached from the shafts within the internal mechanism. Uncontrolled rotation may occur on the left and right roll axes when the rings are removed or damaged.
Cause as FDA categorized it: Component design/selection · Device type: Accelerator, Linear, Medical (IYE)
38 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.